Exam 2 - ACH and Serotonin Flashcards

1
Q

What does the drug vesamicol do?

A

decreases the release of ACH from the terminal button

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Nicotinic receptors:

A

are found on muscle cells at the neuromuscular junction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

A specific marker for serotonin cells is:

A

tryptophan hydroxylase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the two precursors to ACH synthesis?

A

choline and acetyl CoA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the catalyst enzyme for ACH synthesis?

A

choline acetyltransferase - ChAT
- used to make acetylcholine and coenzyme A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the name of the transporter protein that carries ACH into the vesicle? What drug blocks this transporter?

A
  • vesicular ACH transporter protein (VACHT)
  • vesamicol - decreases vesicular ACH and increases ACH in the cytoplasm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does venom from the black widow cause?

A

large release of ACH at peripheral synapses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does botulinum toxin do?

A
  • inhibits ACH release at neuromuscular junctions
  • causes nausea, vomiting, paralysis, asphyxiation
  • also used for cosmetic purposes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What can botox be used to treat?

A
  • spasticity that comes after having a stroke
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What enzyme breaks down ACH? What does this breakdown result in? Does ACH have a reuptake mechanism?

A
  • acetylcholinesterase (AChE)
  • choline (reuptake blocked by hemicholinium) and acetic acid
  • no - the only NT that does not have a reuptake mechanism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the reversible inhibitors of AChE? Irreversible? Explain each.

A
  • reversible:
    • physostigmine - crosses BBB, used to treat glaucoma
    • neostigmine - doesn’t cross BBB, used to treat intestinal tone
  • irreversible:
    • sarin and soman - nerve gases, blocks breakdown of ACH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cholinergic system

A
  • originates in the striatum and basal forebrain
  • play an important role in motor control, cognition and memory
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

192 IGG-Saporin

A

neurotoxin that destroys cholinergic neurons, but spares non-cholinergic neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Alzheimer’s disease causes a significant reduction in _______ neurons.

A

cholinergic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Alzheimer’s disease

A
  • brain disorder/dementia characterized by loss of brain tissue mainly in the cortex and hippocampus, and beta-amyloid plaques and neurofibrillary tangles
  • significantly low levels of ACH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the stages of AZ?

A
  1. mild - 2-4 years, individual is less energetic, minor memory loss, mood swings
  2. moderate - 2-10 years, need assistance with complicated tasks, forget recent events and personal history, become more disoriented and disconnected from reality
  3. severe - 1-3 years, inability to feed themselves, speak, recognize people and control bodily functions
17
Q

Nicotinic receptors (characteristics)

A
  • ionotropic
  • both subunits must be activated
  • agonist is nicotine
  • 5 protein subunits
18
Q

Poison curare

A
  • nicotinic antagonist
  • blocks cholinergic transmission, and causes paralysis and muscle relaxation
19
Q

Muscarinic receptors

A
  • metabotropic
  • main agonist is muscarine
  • 5 subtypes
  • important for reward
20
Q

Knocking out the M5 receptors reduced what?

A

the rewarding effects of morphine

21
Q

Muscarinic agonist

A
  • pilocarpine, acrecoline
  • mimic the effects of parasympathetic activation (salivation, pupil constriction, convulsions)
22
Q

Muscarinic antagonists

A
  • inhibit parasympathetic actions, blocks memory
  • atropine and scopolamine
23
Q

Serotonin synthesis

A
  • precursor is tryptophan, which is catalyzed by tryptophan hydroxylase to make 5-HTP, which is then catalyzed by aromatic amino acid decarboxylase (AADC) to make serotonin
24
Q

Tryptophan brain entry

A
  • in order to get more tryptophan, you need to eat more carbs
  • usually received from food, so when deprived of food, tryptophan is no longer crossing the BBB as much, and its levels increase in the blood instead, rather than in the brain
25
Q

What transporter protein stores serotonin?

A

VMAT2, blocked by reserpine

26
Q

What drugs stimulate the release of serotonin?

A
  • drugs similar to amphetamine: para-chloroamphetamine, fenfluramine, MDMA
27
Q

What does the serotonin/5-HT transporter do? What drugs inhibit this transporter protein? What is the transporter protein metabolized by? What is the end result of this?

A
  • controls reuptake of serotonin
  • SSRIs
  • MAO
  • 5-HIAA
28
Q

Serotonergic system

A
  • majority of serotonergic neurons are in the raphe nucleus
29
Q

When are the neurons of the dorsal raphe nucleus most active?

A
  • during active waking, which shows a coordination with activity and movement
30
Q

5,7, - DHT produces a lesion in the serotonergic system and shows what?

A
  • that the serotonergic system is involved in changes in food intake, reproductive behavior, anxiety, and learning and memory
31
Q

5-HT1A receptors

A
  • reducing CAMP synthesis by inhibiting adenylyl cyclase
  • increases the opening of K+ channels, hyperpolarizing the membrane
32
Q

5-HT1A agonists

A
  • buspirone, isopirone, and 8-OH-DPAT
  • causes hyperphagia, and reduction of anxiety
33
Q

Serotonin and eating behavior

A

serotonin decreases eating behavior

34
Q

What happens if you genetically knock-out the 5-HT1A receptor in mice?

A

increase in anxiety

35
Q

5-HT2A receptors

A
  • opposite of 5-HT1A
  • activate the phosphoinositide second messenger system (increases Ca2+ and activates protein kinase C)
36
Q

5-HT2A agonist

A
  • DOI
  • produces twitching of the head in rats, and hallucinations
37
Q

5-HT2A antagonists

A
  • ketanserin, ritanserin
  • used to treat schizophrenia